|
|
|
Insider
Information: |
Homcy Charles J |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
1,546,413 |
|
Indirect Shares
|
188,122 |
|
|
Direct
Value |
$42,554,742 |
|
|
Indirect Value
|
$3,452,400 |
|
|
Total
Shares |
1,734,535 |
|
|
Total
Value |
$46,007,143 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Millennium Pharmaceuticals Inc |
MLNM |
Director |
2008-05-09 |
0 |
2004-02-17 |
1,119 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2011-05-11 |
62,751 |
2007-01-03 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2019-01-02 |
112,471 |
2019-01-02 |
185,403 |
Premium* |
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2017-10-27 |
67,728 |
2017-10-27 |
1,600 |
Premium* |
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-02-16 |
1,230,085 |
2019-07-01 |
0 |
Premium* |
|
Pliant Therapeutics, Inc. |
PLRX |
Director |
2020-06-02 |
73,378 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2013-08-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
219,433 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2016-11-03 |
5 |
A |
$0.00 |
$0 |
D/D |
14,611 |
227,296 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2016-12-16 |
5 |
A |
$0.00 |
$0 |
D/D |
10,432 |
237,728 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2013-05-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
244,433 |
|
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-29 |
4 |
AS |
$37.50 |
$682,500 |
D/D |
(18,200) |
1,203,767 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-30 |
4 |
AS |
$38.00 |
$380,000 |
D/D |
(10,000) |
1,203,767 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-10-16 |
4 |
AS |
$41.00 |
$420,496 |
D/D |
(10,256) |
1,203,767 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2021-03-01 |
4 |
D |
$71.91 |
$37,681 |
D/D |
(524) |
1,204,764 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,521 |
1,205,288 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2022-05-16 |
4 |
D |
$6.74 |
$10,386 |
D/D |
(1,541) |
1,206,982 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,759 |
1,208,523 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2022-08-16 |
4 |
D |
$11.08 |
$14,260 |
D/D |
(1,287) |
1,209,455 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,210,742 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-30 |
4 |
OE |
$17.00 |
$170,000 |
D/D |
10,000 |
1,213,767 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-10-16 |
4 |
OE |
$17.00 |
$174,352 |
D/D |
10,256 |
1,214,023 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2022-11-16 |
4 |
D |
$9.64 |
$12,542 |
D/D |
(1,301) |
1,214,251 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,215,552 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2023-02-16 |
4 |
D |
$12.64 |
$19,390 |
D/D |
(1,534) |
1,218,368 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,219,902 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2023-05-16 |
4 |
D |
$14.09 |
$18,317 |
D/D |
(1,300) |
1,220,827 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
|
2020-09-25 |
4 |
AS |
$36.68 |
$2,985,455 |
D/D |
(81,057) |
1,221,967 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2023-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,759 |
1,222,127 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2023-08-16 |
4 |
D |
$29.80 |
$38,770 |
D/D |
(1,301) |
1,224,537 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,225,838 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2023-11-16 |
4 |
D |
$28.86 |
$37,547 |
D/D |
(1,301) |
1,226,996 |
0 |
- |
|
108 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|